Login
Integra Lifesciences Holdings Corp logo

Integra Lifesciences Holdings Corp

integralife.com

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.

Financial Snapshot

Revenue
TTM
$1.648B
Gross Margin
TTM
54.3%
Net Income
TTM
-$7.243M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
360.09%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$1.043B
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$1.105M

Stock Price

Loading...
Market Cap: $1.2949 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support